Kurimchak, Alison M <br/><br/>
Intrinsic Resistance to MEK Inhibition through BET Protein-Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer.  [electronic resource] 

 -  Molecular cancer research : MCR  08 2019 
 - 1721-1734 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-18-1332  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>MAP Kinase Kinase 1--antagonists & inhibitors<br/>MAP Kinase Signaling System<br/>Neurofibromin 1--deficiency<br/>Ovarian Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Signal Transduction<br/>Transcription Factors--antagonists & inhibitors<br/>Tumor Cells, Cultured